<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910390</url>
  </required_header>
  <id_info>
    <org_study_id>VITR-1-EMBRYOS</org_study_id>
    <nct_id>NCT00910390</nct_id>
  </id_info>
  <brief_title>Comparison Between Three Freezing Protocols to Preserve Human Embryos</brief_title>
  <official_title>Randomized Comparison to Freeze Human Embryos by Either Vitrification or Slow Freezing Protocols</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized study compares three different freezing methods to store human in vitro
      fertilization (IVF) embryos: vitrification with two commercial kits or slow freezing. After
      information, all patients undergoing IVF treatment can be included in the study. If
      qualified, embryos at different developmental stages will be allocated between the three
      methods. At the end of the first year survival and developmental rates, and implantation and
      pregnancy rates will be analyzed in order to determine the best method.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite all the advances achieved in vitro fertilized treatments, it is known that the
      chances of implantation for fertilised in vitro embryo remain limited, at around 20%.
      Cryopreservation of supernumerary embryos produced during IVF cycles provides an opportunity
      for patients to increase the number of transfers per oocyte harvest cycle, increasing then
      their chances of conception.

      The freezing technique may involve different media and methods, which lead to different
      survival and developmental rates after thawing.

      Vitrification is a new freezing method, which consists in exposing cells to high
      concentrations of cryoprotectants and then cooling them ultra-rapidly; this induces an
      increase in viscosity which favours the formation of a vitreous state without any ice
      crystals formation. This method contrasts with the slow freezing method (currently employed),
      which is based on exposure to very low concentrations of cryoprotectants combined with long
      cooling times and associated with a higher risk of ice crystal formation.

      Both methods can reduce cell survival and embryo ability to develop, either by the high
      concentrations of cryoprotectants in case of vitrification, or by ice crystals formation in
      case of slow freezing. The advantages of vitrification in embryology may be considerable
      because embryos seem more sensitive to ice crystal formation than to cyroportectant
      concentration; consequently, the elimination of office crystal injury may increase their
      survival chances. Additionally in the case of vitrification, the time required for
      equilibration and cooling is considerably reduced as well as the need for expensive equipment
      such as programmable machine is eliminated.

      At present, vitrification and slow freezing are used for the cryopreservation of oocytes and
      embryos at all stages of development. Encouraging results have been obtained with
      vitrification, but no study has randomly compared in one study, the two protocols and
      cryoprotectors. The purpose of this clinic randomised study is to compare three treatments:
      traditional slow freezing method currently employed (control group) and two different
      commercial vitrification methods (experimental groups) to assess the efficacy that this
      technique may involve.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival embryo rate</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delivery rate</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">584</enrollment>
  <condition>Human Embryo Cryopreservation</condition>
  <arm_group>
    <arm_group_label>Slow Freezing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard freezing protocol (slow freezing) of preimplantation embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VIT-Irvine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitrification with Irvine solution (rapid freezing) of preimplantation embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VIT-Vitrolife</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitrification (rapid freezing) with Vitrolife solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Slow freezing</intervention_name>
    <description>Embryos at different developmental stages will be frozen using a solution that contains propanediol and sucrose, individually placed in high security straws, cooled with a programmator and stored in liquid nitrogen.</description>
    <arm_group_label>Slow Freezing</arm_group_label>
    <other_name>Home-made solutions</other_name>
    <other_name>propanediol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VIT-Irvine</intervention_name>
    <description>Embryos at different developmental stages will be frozen using the vitrification solution according to the manufacturer's instructions, individually placed in high security vitrification devices and plunged directly in liquid nitrogen for storing.</description>
    <arm_group_label>VIT-Irvine</arm_group_label>
    <other_name>IRVINE, California</other_name>
    <other_name>ethylene glycol</other_name>
    <other_name>DMSO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vit-Vitrolife</intervention_name>
    <description>Embryos at different developmental stages will be frozen using the vitrification solution according to the manufacturer's instructions, individually placed in high security vitrification devices and plunged directly in liquid nitrogen for storing.</description>
    <arm_group_label>VIT-Vitrolife</arm_group_label>
    <other_name>VITROLIFE, Sweden</other_name>
    <other_name>ethylene glycol</other_name>
    <other_name>propanediol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infertility requiring IVF

        Exclusion Criteria:

          -  Women's age &gt; 43 years

          -  Patients positive for hepatitis B or C

          -  Patients positive for HIV
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Delbaere, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Fertility Clinic, Hospital Erasme</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVF laboratory, Hospital Erasme, Route de Lennik 808</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Al-Hasani S, Ozmen B, Koutlaki N, Schoepper B, Diedrich K, Schultze-Mosgau A. Three years of routine vitrification of human zygotes: is it still fair to advocate slow-rate freezing? Reprod Biomed Online. 2007 Mar;14(3):288-93.</citation>
    <PMID>17359578</PMID>
  </reference>
  <reference>
    <citation>Balaban B, Urman B, Ata B, Isiklar A, Larman MG, Hamilton R, Gardner DK. A randomized controlled study of human Day 3 embryo cryopreservation by slow freezing or vitrification: vitrification is associated with higher survival, metabolism and blastocyst formation. Hum Reprod. 2008 Sep;23(9):1976-82. doi: 10.1093/humrep/den222. Epub 2008 Jun 10.</citation>
    <PMID>18544577</PMID>
  </reference>
  <reference>
    <citation>Desai N, Blackmon H, Szeptycki J, Goldfarb J. Cryoloop vitrification of human day 3 cleavage-stage embryos: post-vitrification development, pregnancy outcomes and live births. Reprod Biomed Online. 2007 Feb;14(2):208-13.</citation>
    <PMID>17298725</PMID>
  </reference>
  <reference>
    <citation>Escribá MJ, Zulategui JF, Galán A, Mercader A, Remohí J, de los Santos MJ. Vitrification of preimplantation genetically diagnosed human blastocysts and its contribution to the cumulative ongoing pregnancy rate per cycle by using a closed device. Fertil Steril. 2008 Apr;89(4):840-6. Epub 2007 Aug 6.</citation>
    <PMID>17681342</PMID>
  </reference>
  <reference>
    <citation>Huang CC, Lee TH, Chen SU, Chen HH, Cheng TC, Liu CH, Yang YS, Lee MS. Successful pregnancy following blastocyst cryopreservation using super-cooling ultra-rapid vitrification. Hum Reprod. 2005 Jan;20(1):122-8. Epub 2004 Oct 7.</citation>
    <PMID>15471932</PMID>
  </reference>
  <reference>
    <citation>Kasai M, Mukaida T. Cryopreservation of animal and human embryos by vitrification. Reprod Biomed Online. 2004 Aug;9(2):164-70. Review.</citation>
    <PMID>15333245</PMID>
  </reference>
  <reference>
    <citation>Kattera S, Chen C. Cryopreservation of embryos by vitrification: current development. Int Surg. 2006 Sep-Oct;91(5 Suppl):S55-62. Review.</citation>
    <PMID>17436605</PMID>
  </reference>
  <reference>
    <citation>Kuwayama M, Vajta G, Ieda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online. 2005 Nov;11(5):608-14.</citation>
    <PMID>16409712</PMID>
  </reference>
  <reference>
    <citation>Kuwayama M. Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007 Jan 1;67(1):73-80. Epub 2006 Oct 20. Review.</citation>
    <PMID>17055564</PMID>
  </reference>
  <reference>
    <citation>Liebermann J, Nawroth F, Isachenko V, Isachenko E, Rahimi G, Tucker MJ. Potential importance of vitrification in reproductive medicine. Biol Reprod. 2002 Dec;67(6):1671-80. Review.</citation>
    <PMID>12444040</PMID>
  </reference>
  <reference>
    <citation>Liebermann J, Dietl J, Vanderzwalmen P, Tucker MJ. Recent developments in human oocyte, embryo and blastocyst vitrification: where are we now? Reprod Biomed Online. 2003 Dec;7(6):623-33. Review.</citation>
    <PMID>14748959</PMID>
  </reference>
  <reference>
    <citation>Liebermann J, Tucker MJ. Comparison of vitrification and conventional cryopreservation of day 5 and day 6 blastocysts during clinical application. Fertil Steril. 2006 Jul;86(1):20-6. Epub 2006 Jun 8.</citation>
    <PMID>16762345</PMID>
  </reference>
  <reference>
    <citation>Loutradi KE, Kolibianakis EM, Venetis CA, Papanikolaou EG, Pados G, Bontis I, Tarlatzis BC. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil Steril. 2008 Jul;90(1):186-93. Epub 2007 Nov 5. Review.</citation>
    <PMID>17980870</PMID>
  </reference>
  <reference>
    <citation>Nawroth F, Rahimi G, Isachenko E, Isachenko V, Liebermann M, Tucker MJ, Liebermann J. Cryopreservation in assisted reproductive technology: new trends. Semin Reprod Med. 2005 Nov;23(4):325-35. Review.</citation>
    <PMID>16317621</PMID>
  </reference>
  <reference>
    <citation>Rama Raju GA, Haranath GB, Krishna KM, Prakash GJ, Madan K. Vitrification of human 8-cell embryos, a modified protocol for better pregnancy rates. Reprod Biomed Online. 2005 Oct;11(4):434-7.</citation>
    <PMID>16274602</PMID>
  </reference>
  <reference>
    <citation>Stehlik E, Stehlik J, Katayama KP, Kuwayama M, Jambor V, Brohammer R, Kato O. Vitrification demonstrates significant improvement versus slow freezing of human blastocysts. Reprod Biomed Online. 2005 Jul;11(1):53-7.</citation>
    <PMID>16102287</PMID>
  </reference>
  <reference>
    <citation>Takahashi K, Mukaida T, Goto T, Oka C. Perinatal outcome of blastocyst transfer with vitrification using cryoloop: a 4-year follow-up study. Fertil Steril. 2005 Jul;84(1):88-92.</citation>
    <PMID>16009162</PMID>
  </reference>
  <reference>
    <citation>Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online. 2006 Jun;12(6):779-96. Review.</citation>
    <PMID>16792858</PMID>
  </reference>
  <reference>
    <citation>Youssry M, Ozmen B, Zohni K, Diedrich K, Al-Hasani S. Current aspects of blastocyst cryopreservation. Reprod Biomed Online. 2008 Feb;16(2):311-20. Review.</citation>
    <PMID>18284893</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasme University Hospital</investigator_affiliation>
    <investigator_full_name>Fasano Giovanna</investigator_full_name>
    <investigator_title>Clinical Embryologist</investigator_title>
  </responsible_party>
  <keyword>IVF</keyword>
  <keyword>embryo cryopreservation</keyword>
  <keyword>vitrification</keyword>
  <keyword>Human Embryo</keyword>
  <keyword>Embryonic development</keyword>
  <keyword>Pregnancy rate</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ethylene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

